14-day Premium Trial Subscription Try For FreeGet Free
RSI low/high Values: [ 25 - 75 ]
* StockInvest.us uses dynamically calculated RSI max/min levels to determine when stock is oversold or overbought based on historical behavior.
AI Analysis of FGEN
Powered by GPT-4
Upgraded!
Stock Analysis
Risk Assessment
Trading Strategy

High volatility in FibroGen stock price on Friday which ended trading at $0.628
(Updated on Dec 01, 2023)


Buy candidate since Nov 30, 2023 Gain 13.76% PDF
The FibroGen stock price gained 13.76% on the last trading day (Friday, 1st Dec 2023), rising from $0.552 to $0.628. It has now gained 4 days in a row. It will be exciting to see whether it manages to continue gaining or take a minor break for the next few days. During the last trading day the stock fluctuated 16.36% from a day low at $0.550 to a day high of $0.640. The price has risen in 6 of the last 10 days and is up by 25.68% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 266 thousand more shares were traded than the day before. In total, 3 million shares were bought and sold for approximately $1.64 million.

Ready to grow your portfolio? Here's your beginner's guide to opening a free brokerage account.

Given the current short-term trend, the stock is expected to fall -47.73% during the next 3 months and, with a 90% probability hold a price between $0.131 and $0.328 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.

FGEN Signals & Forecast

Mostly positive signals in the chart today. The FibroGen stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock, but the stock has a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections down, there will be some support from the lines at $0.506 and $0.525. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Friday, November 10, 2023, and so far it has risen 65.32%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal.

Get your hands on a piece of history – invest in multi-million dollar paintings from $10k with Masterworks.

Support, Risk & Stop-loss for FibroGen stock

FibroGen finds support from accumulated volume at $0.620 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.

This stock may move very much during the day (volatility) and with a very large prediction interval from the Bollinger Band this stock is considered to be "very high risk". During the last day, the stock moved $0.0900 between high and low, or 16.36%. For the last week, the stock has had daily average volatility of 17.19%.

Our recommended stop-loss: $0.606 (-3.54%) (This stock has very high daily movements and this gives very high risk. There is a buy signal from a pivot bottom found 14 days ago.)

Trading Expectations (FGEN) For The Upcoming Trading Day Of Monday 4th

For the upcoming trading day on Monday, 4th we expect FibroGen to open at $0.606, and during the day (based on 14 day Average True Range), to move between $0.548 and $0.709, which gives a possible trading interval of +/-$0.0804 (+/-12.80%) up or down from last closing price. If FibroGen takes out the full calculated possible swing range there will be an estimated 25.60% move between the lowest and the highest trading price during the day.

Since the stock is closer to the support from accumulated volume at $0.620 (1.32%) than the resistance at $0.719 (14.39%), our systems sees the trading risk/reward intra-day as attractive and believe profit can be made before the stock reaches first resistance..

Is FibroGen stock A Buy?

FibroGen holds several positive signals and despite the stock being in a falling trend, we considered it to be a good choice at these current levels. We expect FibroGen stock will perform very well in the next 3 months. We have upgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Strong Buy candidate.

Current score: 5.403 Open Broker Account

Strong Buy Candidate Upgraded

Predicted Opening Price for FibroGen of Monday, December 4, 2023

The predicted opening price is based on yesterday's movements between high, low, and closing price.

Fair opening price December 4, 2023 Current price
$0.606 $0.628 (Overvalued)

Remember To Visit Our YouTube Channel


Fibonacci Support & Resistance Levels

Level Price
Resistance R3 0.696 10.78 %
R2 0.662 5.31 %
R1 0.641 1.93 %
Current price: 0.628
Support S1 0.572 -9.01 %
S2 0.551 -12.39 %
S3 0.516 -17.87 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 0.750 19.30 %
R2 0.740 17.78 %
R1 0.719 14.39 %
Current price 0.628
Support S1 0.620 -1.32%
S2 0.552 -12.09%
S3 0.499 -20.66%
What is the symbol for FibroGen Stock and on which exchange is it traded?
The symbol for FibroGen is FGEN and it is traded on the NASDAQ (NASDAQ Stock Exchange).

Should I buy or sell FibroGen Stock?
FibroGen holds several positive signals and despite the stock being in a falling trend, we considered it to be a good choice at these current levels. We expect FibroGen stock will perform very well in the next 3 months. We have upgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Strong Buy candidate.

How to buy FibroGen Stock?
FibroGen Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy FibroGen Stock.

What's the current price of FibroGen Stock?
As of the end of day on the 2023-12-01, the price of an FibroGen (FGEN) share was $0.628.

What is the 52-week high and low for FibroGen Stock?
The 52-week high for FibroGen Stock is $25.69 and the 52-week low is $0.335.

What is the market capitalization of FibroGen Stock?
As of the 2023-12-01, the market capitalization of FibroGen is 54.323M.

When is the next earnings date for FibroGen?
The upcoming earnings date for FibroGen is 2024-02-26 00:00:00.

Click to get the best stock tips daily for free!

About FibroGen

FibroGen FibroGen, Inc., a biopharmaceutical company, discovers, develops, and commercializes therapeutics to treat serious unmet medical needs. The company is developing Roxadustat, an oral small molecule inhibitor of hypoxia inducible factor prolyl hydroxylases, which has completed Phase III clinical development for the treatment of anemia in chronic kidney disease in the United States, Europe, China, and Japan; and in Phase II/III development in China ... FGEN Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT